<a href="https://laohu8.com/S/THRD">Third Harmonic Bio</a> Inc. Announces Voluntary Delisting from Nasdaq and Plans to Terminate SEC Reporting Obligations
Third Harmonic Bio Inc. announced a regulatory development regarding its stock listing. On July 31, 2025, the company filed a Form 25 with the Securities and Exchange Commission $(SEC.UK)$ to voluntarily delist its common stock under Section 12(b) of the Securities Exchange Act of 1934. The delisting will become effective around August 10, 2025. Consequently, trading of the company's stock on Nasdaq was suspended before the market opened on July 31, 2025. Additionally, Third Harmonic Bio plans to file a Form 15 with the SEC on August 11, 2025, to terminate the registration of its common stock under Section 12(g) of the Exchange Act, suspending its reporting obligations. This move is part of the company's previously approved Plan of Dissolution, with a certificate of dissolution filed on the same day, July 31, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Third Harmonic Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-170428), on July 31, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。